Skip to main content
. 2012 Feb 1;86(2):359–372. doi: 10.4269/ajtmh.2012.11-0525

Table 4.

Comparisons for pharmacovigilance databases

Reference Age group (years) SAEs YEL-AND YEL-AVD
RR 95% CI RR 95% CI RR 95% CI
12 60–69 5.9 1.6–22.2 N/A 0.6–21.1 4.4 0.4–48.7
15 65–74 3.7 1.3–10.7 1.49–53.5 N/A N/A N/A N/A
16 ≥ 65 8.95 0.81–9.81 N/A N/A N/A N/A
17 65–74 2.82 3.5 N/A N/A N/A N/A
12 ≥ 70 10.4 2.7–40.2 13.4 1.4–128.5 2.4 0.2–26.2
16 ≥ 75 11.6 3.7–7.36 N/A N/A N/A N/A
17 > 75 0 Undefined 0 Undefined 0 Undefined